Level Biotechnology Inc. (3118.TWO)
TWD 31.65
(1.93%)
TWD 31.65
(1.93%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 822.67 Million TWD | 1.25% |
| 2022 | 812.53 Million TWD | 3.16% |
| 2021 | 787.62 Million TWD | 1.89% |
| 2020 | 772.98 Million TWD | 3.04% |
| 2019 | 750.18 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 838.24 Million TWD | 1.89% |
| 2024 Q2 | 834.24 Million TWD | -0.48% |
| 2023 Q4 | 822.67 Million TWD | 4.05% |
| 2023 FY | 822.67 Million TWD | 1.25% |
| 2023 Q1 | 828.14 Million TWD | 1.92% |
| 2023 Q2 | 825.36 Million TWD | -0.34% |
| 2023 Q3 | 790.68 Million TWD | -4.2% |
| 2022 Q4 | 812.53 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 71.641% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -23.762% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -49.918% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 30.053% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 27.444% |
| Visgeneer Inc. | 397.17 Million TWD | -107.131% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 61.896% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 6.842% |
| Neith Corporation | 192.15 Million TWD | -328.134% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1018.4% |
| Enimmune corporation | 604.82 Million TWD | -36.018% |
| TaiRx, Inc. | 833.74 Million TWD | 1.328% |
| EirGenix Inc. | 11.16 Billion TWD | 92.63% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -43.538% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 51.957% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -456.108% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 21.686% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -173.284% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -86.466% |
| RBC Bioscience Corporation | 753.79 Million TWD | -9.138% |
| BiOptic Inc. | 613.77 Million TWD | -34.035% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -542.477% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 29.062% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -27.576% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 73.516% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 78.181% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 86.497% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -210.845% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 78.873% |
| GlycoNex Incorporation | 1.55 Billion TWD | 47.021% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -9.899% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -117.43% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 77.127% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 53.748% |
| VBI | 452.1 Million TWD | -81.966% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 73.342% |
| NaviFUS Corp. | 490.53 Million TWD | -67.709% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 32.882% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 39.659% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -55.472% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 29.165% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 50.33% |
| AP Biosciences Inc | 890.75 Million TWD | 7.643% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 90.352% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -153.795% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 38.314% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 69.655% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 94.645% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -100.526% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -107.3% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 60.371% |
| TCI GENE Inc. | 1.16 Billion TWD | 29.441% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -179.269% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 39.657% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 12.645% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -17.785% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 79.193% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 78.479% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 33.107% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 85.32% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 22.536% |
| Acepodia, Inc. | 6.81 Billion TWD | 87.935% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 78.501% |